Articles Archives - Page 83 of 811

ThursdaySep 04, 2025 9:00 am

Strawberry Fields REIT Inc. (NYSE American: STRW) Is ‘One to Watch’

Strawberry Fields REIT generated $18.9 million in AFFO and $8.7 million in net income for the second quarter of 2025. Rental income rose 29% year-over-year, reflecting growth from acquisitions and lease renewals. The company owns and leases 142 healthcare facilities with over 15,500 licensed beds across 10 states. Long-term triple-net leases with built-in escalators support predictable, recurring revenue. Recent acquisitions in Missouri and Oklahoma added $7.1 million in new annual base rent. Strawberry Fields REIT (NYSE American: STRW) is a self-administered real estate investment trust engaged in the ownership, acquisition, development, and leasing of skilled nursing and other healthcare-related properties. Initially…

WednesdaySep 03, 2025 11:15 am

Brera Holdings PLC (NASDAQ: BREA) Actively Capitalizing on Sports Investing Market Growth

Public sports stocks have surged in recent years, drawing more institutional and retail investor interest. Brera Holdings operates a multi-club ownership strategy spanning Europe, Africa, and Asia. The company completed its majority acquisition of SS Juve Stabia, now competing in Italy’s Serie B. Juve Stabia’s squad value rose 245% to $32 million during the 2024–25 season. Brera is one of only two MCOs active in Italy’s Serie B, alongside City Football Group. The firm’s strategy emphasizes portfolio growth, bottom-up value creation, and fan-to-investor pathways. Public markets have started to embrace sports franchises and related companies in a way rarely seen…

WednesdaySep 03, 2025 10:30 am

GlobalTech Corp. (GLTK) Pioneers AI Innovation, Frontier Technology Growth Worldwide

GlobalTech’s mission is centered on creating exponential value for its portfolio companies while delivering measurable results for shareholders A key component of the company’s strategy is the establishment of AI and Big Data Center of Excellence (“CoE”), that focus on advanced technology development While the company’s broader mission drives its long-term vision, GlobalTech recently reported financial results for Q2 2025 GlobalTech (OTC: GLTK) is a U.S.-based technology holding company at the forefront of innovation, specializing in artificial intelligence (“AI”), big data and digital infrastructure. With a mission to empower visionary companies and innovation-led enterprises, GlobalTech focuses on enabling growth through…

WednesdaySep 03, 2025 9:45 am

Oncotelic Therapeutics Inc. (OTLC) Is ‘One to Watch’

The company’s lead candidate, OT-101, is currently in a Phase 3 trial for pancreatic cancer and is advancing toward combination studies with checkpoint inhibitors. A joint venture with GMP Biotechnology enables Oncotelic to conduct low-cost research and development, operate in-house GMP manufacturing, and support a rapidly expanding nanoparticle pipeline trademarked Deciparticle(TM). A strategic partnership with Shanghai Medicilon supports rapid IND filings for up to 20 drug candidates, significantly accelerating development timelines. Oncotelic’s proprietary AI platform, PDAOAI, enhances regulatory and research workflows while offering public engagement tools for added transparency. The company maintains a multi-indication pipeline spanning oncology, Parkinson’s disease, erectile…

WednesdaySep 03, 2025 9:00 am

MoneyShow Experts to Gather Online Soon for the Oil, Gas, and Renewables Bootcamp

Global demand for energy is picking up, in part due to rising power demand fueled by new technologies like AI and EVs. Now, investors can learn new ways to profit at the MoneyShow Virtual Expo, scheduled for Sept. 9-10, 2025. Attendees at the online event will get tips and recommendations across the natural gas, crude oil, and alternative energy sectors. Participants can also engage with eminent industry veterans to learn novel ways and tools to protect and grow their wealth. MoneyShow Virtual Expos are designed to provide investors and traders with powerful market opportunities and resources to maximize returns. The…

TuesdaySep 02, 2025 12:00 pm

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Building Market Awareness Through Strategic Education Platform

BreastCT.com launches as a comprehensive educational resource focused on dedicated breast CT technology and IzoView's clinical advantages for dense breast tissue imaging Platform designed to evolve alongside company progression through clinical studies, regulatory phases, and commercial launch milestones Strategic positioning within successful imaging category creation context provides clear market reference framework for IzoView's commercial potential The Pre-Commercial Challenge: Educating Markets on Breakthrough Technology Medical device companies developing breakthrough technologies face a fundamental commercialization challenge beyond regulatory approval: market education. When innovations represent genuine advances over existing standards of care, successful adoption requires comprehensive stakeholder education across patients, clinicians, and healthcare…

TuesdaySep 02, 2025 11:15 am

Wearable Devices Ltd. (NASDAQ: WLDS): How Neural Interface Patents Are Securing the Future of Touchless Control

WLDS's newly granted U.S. patent protects groundbreaking neural interface technology that measures weight, torque, and force directly from wrist-based sensors with applications spanning XR, industrial automation, and assistive technology The patent encompasses voice-controlled interfaces and innovations in brain-computer interfaces, strengthening the company's intellectual property position in the rapidly expanding $260 billion AI wearables market Patent protection covers real-world physical measurement capabilities that differentiate WLDS from gesture-only competitors, opening industrial and manufacturing applications beyond consumer electronics The neural interface revolution is unfolding differently than most technological observers anticipated. While industry attention focused on brain-computer interfaces requiring surgical implants or complex headsets,…

TuesdaySep 02, 2025 10:30 am

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Advances Sustainable Development in Alaska’s Ambler Mining District

Trilogy Metals is boldly advancing one of North America’s most promising mineral districts: the Ambler Mining District in Alaska TMQ is a significant player in one of the richest and most prospective copper-dominant areas globally The company continues to advance its projects with a focus on sustainable development, community engagement and environmental responsibility With a focus on high-grade copper, zinc, lead, gold and silver, Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) is not only exploring and developing critical metal resources but also championing responsible, sustainable mining practices that balance economic growth with environmental stewardship. The company is boldly advancing one…

TuesdaySep 02, 2025 9:45 am

SuperCom Ltd. (NASDAQ: SPCB) Secures New U.S. Contracts, Expands Presence into 11th State in Under a Year

SuperCom secures a second electronic monitoring (“EM”) contract in Alabama, strengthening its foothold in the state. The company has entered 11 new U.S. states since mid-2024, including Tennessee in July. Contracts follow a recurring revenue model, with agencies billed per daily active unit. Referrals from existing clients have driven repeat contracts, highlighting customer satisfaction. SuperCom’s PureSecurity(TM) Suite supports GPS monitoring, house arrest, and domestic violence prevention programs. Rising adoption of EM solutions reflects demand for alternatives to incarceration and data-driven public safety management. SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, is accelerating its push…

TuesdaySep 02, 2025 9:00 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression

The FDA designation expands the drug’s potential patient pool tenfold, to an estimated 13 million Americans who consider suicide annually. Clinical trials demonstrated rapid and statistically significant reductions in suicidal ideation with IV ketamine versus placebo and comparators. Fast Track status makes NRX-100 eligible for Accelerated Approval and the Commissioner's National Priority Voucher program. NRx is preparing an expanded access policy and seeking meetings with FDA leadership to align on data submission. The U.S. suicidal depression market is estimated at more than $3 billion annually. NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug…

Site Search

Company Search

Category: Articles